Daiichi Sankyo
Moumita Chatterjee, Ph.D., ACRP-CP, is an experienced oncology professional currently serving as a National Field Trainer and Principal Medical Science Liaison at Daiichi Sankyo US since May 2023, focusing on lung and gastrointestinal oncology and antibody-drug conjugates (ADCs). Previously, Moumita worked at Sanofi as a Senior Medical Science Liaison for solid tumors, and held similar roles at Eisai US and Coherus BioSciences. With a solid foundation in oncology clinical trials as an Oncology Clinical Trials Coordinator at SCL Health, along with research management experience at OhioHealth, Moumita's expertise is further anchored by postdoctoral research in cancer biology at The Ohio State University Wexner Medical Center and a Ph.D. in Biological Sciences from the University of Delaware.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.